PDBio

PDBio, as a global practitioner of innovative peptide drugs, utilizes multi-omics technology to obtain hundreds of millions of natural peptide molecules derived from animal toxins and is committed to establishing the largest natural active peptide library. PDBio's unique technology will address the research bottleneck of toxic animal peptides in China, overcome the chokepoint issue of the lack of sources for peptide drug development, accelerate the research of animal-based traditional Chinese medicine, and promote China’s R&D capabilities in innovative peptide drugs.